CXCL9
Reaktivität: Human
WB
Wirt: Kaninchen
Polyclonal
FITC
Applikationshinweise
ELISA: 2-4 µg/mL, Inhibition: 5-10 µg/mL, WB: 0.5-2 µg/mL Optimal conditions should be determined by the investigator.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Konzentration
Lot specific
Buffer
Lyophilized from PBS.
Handhabung
Avoid repeated freeze/thaw cycles. Dilute only prior to immediate use.
Lagerung
4 °C/-20 °C
Informationen zur Lagerung
Store at -20 °C until reconstitution. Following reconstitution product may be stored at 4 °C in the short term. For long term storage aliquot and freeze at -20 °C.
MIG, a CXC chemokine, is produced by IFN stimulated monocytes, macrophages and endothelial cells. It signals through the CXCR3 receptor. MIG selectively chemoattracts Th1 lymphocytes, and also exerts other activities including inhibition of tumor growth, angiogenesis, and inhibition of colony formation of hematopoietic progenitors. Human MIG is active on Mouse cells. Synonyms: Monoclonal MIG antibody, Anti-MIG antibody, Monokine Induced by Interferon-gamma antibody, CXCL9 antibody.